Identify the best chronic pain non-opioid treatment for you.
Preprocessing and analysis for proteomics and interactomics biological data.
Apply predictive analytics on multi-omics data with InSyBio Biomarkers.
Dietary and nutritional products affect individuals differently based on their genetic predisposition, nutritional lifestyle, exercises habits, and their environments.
More than 50% of clinical trials currently fail due to low efficacy.
Several markers and tests have been introduced in the market for diagnosing cancer types and other diseases.
Preclinical research, when related to molecular biology data analysis, mostly includes statistical analysis to identify significantly differentiated molecules in the phenotypes under study.
Publishing scientific findings in domain-specific journals and announcing them in scientific conferences has become an essential part of today’s research environment.
March 2, 2021
In an effort to find a better alternative to the traditionally prescribed opioid analgesics, InSyBio worked in collaboration with Clarity Science LLC and developed a machine learning-based tool for predicting the response of chronic pain patients to 4 different non-opioid pain treatment formulations.
November 26, 2019
In a bold approach to revolutionize a vital part of the pharmaceutical/nutraceutical industry and change the stagnant norm that is the clinical trial process, JSS Medical Research Inc. has strategically partnered with InSyBio, a leading bioinformatics company, to drive desperately needed transformation.
November 15, 2019
The new version of InSyBio Suite enables the fast and accurate analysis of omics data by non-bioinformatics experts empowered with novel techniques to explore the dark matter of the transcriptomics data.
